Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
J Neuroimmunol ; 298: 32-41, 2016 09 15.
Article in English | MEDLINE | ID: mdl-27609273

ABSTRACT

Experimental autoimmune encephalomyelitis (EAE) is a common rodent model for multiple sclerosis (MS). Yet, the long-term consequences for retina and optic nerve (ON) are unknown. C57BL/6 mice were immunized with an encephalitogenic peptide (MOG35-55) and the controls received the carriers or PBS. Clinical symptoms started at day 8, peaked at day 14, and were prevalent until day 60. They correlated with infiltration and demyelination of the ON. In MOG-immunized animals more microglia cells in the ONs and retinas were detected at day 60. Additionally, retinal ganglion cell (RGC) loss was combined with an increased macroglia response. At this late stage, an increased number of microglia was associated with axonal damage in the ON and in the retina with RGC loss. Whether glial activation contributes to repair mechanisms or adversely affects the number of RGCs is currently unclear.


Subject(s)
Encephalomyelitis, Autoimmune, Experimental/pathology , Microglia/physiology , Optic Nerve/pathology , Retina/pathology , Analysis of Variance , Animals , Axons/drug effects , Axons/pathology , Calcium-Binding Proteins/metabolism , Central Nervous System Stimulants/toxicity , Disease Models, Animal , Encephalomyelitis, Autoimmune, Experimental/chemically induced , Freund's Adjuvant/toxicity , Glial Fibrillary Acidic Protein/metabolism , Mice , Mice, Inbred C57BL , Microfilament Proteins/metabolism , Microglia/drug effects , Myelin-Oligodendrocyte Glycoprotein/toxicity , Optic Nerve/drug effects , Peptide Fragments/toxicity , Picrotoxin/toxicity , Protein Kinase C-alpha/metabolism , Retina/drug effects , Transcription Factor Brn-3A/metabolism , Vimentin/metabolism
2.
J Refract Surg ; 31(3): 146-52, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25751829

ABSTRACT

PURPOSE: To compare femtosecond laser-assisted cataract surgery without the use of ophthalmic viscosurgical device (OVD) with standard phacoemulsification using OVD. METHODS: This was a prospective, randomized, single-center trial of 37 patients (74 eyes) diagnosed as having significant cataract in both eyes. Randomly, one eye underwent standard phacoemulsification with OVD (the OVD group); this group acted as controls. The other eye was treated with the femtosecond laser; the subsequent manual part of the procedure was performed without OVD (non-OVD group). Time of surgery, amount of fluid used during phacoemulsification, central corneal thickness, intraocular pressure, endothelial cell count, and visual acuity were documented over the 6-month follow-up. RESULTS: There were no major complications and no significant difference in overall surgery time (non-OVD: 375 ± 81 seconds; OVD: 362 ± 43 seconds; P = .713) and in the quantity of fluid passing through the eye (non-OVD: 187 ± 35 mL; OVD: 186 ± 27 mL; P = .952) between groups. Endothelial cell loss after 6 months was not significantly different between groups (non-OVD: -2.4%; OVD: -2.7%; P = .880). Central corneal thickness was not different at 1 week postoperatively between groups (non-OVD: 575 ± 45 µm; OVD: 573 ± 46 µm; P = .820). Three patients in the OVD group and one patient in the non-OVD group experienced intraocular pressure greater than 25 mm Hg at 1 day postoperatively. There were no significant differences in corrected distance visual acuity between groups (logMAR non-OVD: 0.024; OVD: 0.038; P = .461). CONCLUSIONS: Femtosecond laser-assisted treatment allows the cataract surgeon to perform phacoemulsification and intraocular lens implantation without the use of OVD at no additional risk to the corneal endothelium. Furthermore, there was a tendency toward fewer increases in intraocular pressure in patients treated with the femtosecond laser.


Subject(s)
Chondroitin Sulfates/administration & dosage , Corneal Endothelial Cell Loss/diagnosis , Endothelium, Corneal/pathology , Hyaluronic Acid/administration & dosage , Laser Therapy , Lens Implantation, Intraocular , Phacoemulsification/methods , Viscosupplements/administration & dosage , Aged , Aged, 80 and over , Cell Count , Drug Combinations , Female , Humans , Intraocular Pressure/physiology , Male , Middle Aged , Operative Time , Prospective Studies , Visual Acuity/physiology
3.
J Refract Surg ; 29(11): 784-7, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23957755

ABSTRACT

PURPOSE: To describe a technique for performing femtosecond laser-assisted cataract surgery without the use of ophthalmic viscosurgical devices (OVDs). METHODS: After laser pretreatment, the anterior chamber is stabilized with balanced salt solution during lens and cortex aspiration. A preloaded intraocular lens is implanted under irrigation. RESULTS: In 23 eyes undergoing surgery without the use of OVDs, no complications were observed within a 1-month follow-up period. The time for surgery and the amount of fluid that went into the eye were similar to those of a standard procedure. There was no remarkable increase in intraocular pressure or corneal thickness. All patients achieved a significant increase in corrected distance visual acuity after surgery. CONCLUSIONS: The significant reduction of phacoemulsification use after femtosecond laser application might render the use of OVDs obsolete in many cases.


Subject(s)
Lasers, Excimer/therapeutic use , Lens Implantation, Intraocular , Phacoemulsification/methods , Viscosupplements , Acetates/therapeutic use , Aged , Aged, 80 and over , Drug Combinations , Female , Humans , Male , Middle Aged , Minerals/therapeutic use , Prospective Studies , Refraction, Ocular/physiology , Sodium Chloride/therapeutic use , Treatment Outcome , Visual Acuity/physiology
4.
J Cataract Refract Surg ; 39(9): 1286-90, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23988240

ABSTRACT

We describe a technique for femtosecond laser-assisted bag-in-the-lens (BIL) intraocular lens (IOL) implantation. Anterior capsulotomy and lens division into small pieces are performed by the laser. A fluid-filled interface makes it possible to re-dock the laser to the eye for posterior capsulotomy after the eye has been opened for lens aspiration without complications. The integrated optical coherence tomography also visualizes the posterior capsule, allowing a centered central posterior capsulotomy for uncomplicated IOL positioning. In 31 patients, no complications were observed within a 1-month follow-up. Femtosecond laser-assisted cataract surgery facilitated the BIL technique.


Subject(s)
Anterior Capsule of the Lens/surgery , Lens Implantation, Intraocular/methods , Low-Level Light Therapy/methods , Phacoemulsification/methods , Posterior Capsulotomy/methods , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Surgery, Computer-Assisted , Tomography, Optical Coherence , Treatment Outcome , Visual Acuity/physiology
5.
J Cataract Refract Surg ; 39(9): 1314-20, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23988243

ABSTRACT

PURPOSE: To evaluate the efficacy of different treatment modalities in eyes with small pupils before femtosecond laser-assisted cataract surgery. SETTING: Ruhr University Eye Clinic, Bochum, Germany. DESIGN: Prospective clinical trial. METHODS: Eyes with an intraoperative pupil size smaller than 5.5 mm received sequential treatments to achieve a pupil larger than 5.5 mm in 3 steps: (1) intracameral administration of epinephrine solution, (2) additional viscomydriasis, and (3) implantation of a Malyugin ring pupil expander. When a step enlarged the pupil to at least 5.5 mm, femtosecond laser-assisted cataract surgery with an anterior capsulotomy diameter of at least 4.5 mm and 350 µm nuclear fragmentation grids, ultrasound phacoemulsification, and intraocular lens implantation were performed. Main outcome measures were achieved preoperative pupil size in each sequential treatment group and analysis of intraoperative complications. RESULTS: Of 850 eyes scheduled for cataract surgery, 40 received sequential treatments. To achieve a pupil larger than 5.5 mm, epinephrine was sufficient in 7% of the eyes; additional viscomydriasis was necessary in 25%, and the pupil expander was implanted in 68%. The most frequent comorbidities were pseudoexfoliation of the lens capsule (30.0%) and intraoperative floppy-iris syndrome (12.5%). Tongue-like lesions of the capsulotomies were detected in 5 eyes. CONCLUSIONS: The 3-step treatment allowed the surgeon to increase the efficiency and safety of femtosecond-assisted cataract surgery in eyes with a small preoperative pupil, providing good safety margins at the pupil boundary for the capsulotomy and the softened nuclear volume.


Subject(s)
Low-Level Light Therapy/methods , Phacoemulsification/methods , Pupil Disorders/surgery , Aged , Aged, 80 and over , Anterior Capsule of the Lens/surgery , Epinephrine/administration & dosage , Female , Humans , Intraoperative Complications , Male , Middle Aged , Mydriatics/administration & dosage , Prostheses and Implants , Pupil/drug effects , Pupil Disorders/complications , Surgery, Computer-Assisted , Tomography, Optical Coherence , Treatment Outcome , Viscosupplements/therapeutic use
8.
J Cataract Refract Surg ; 39(9): 1307-13, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23871112

ABSTRACT

PURPOSE: To quantify changes in endothelial cell counts and corneal thickness measurements in patients having standard phacoemulsification compared with femtosecond laser-assisted cataract removal. SETTING: Ruhr University Eye Clinic, Bochum, Germany. DESIGN: Prospective randomized intraindividual cohort study. METHODS: One eye of each patient had standard phacoemulsification (control group) and the other eye had femtosecond laser-assisted phacoemulsification (study group), both with intraocular lens implantation. Pulsed ultrasound energy was used for phacoemulsification. Noncontact endothelial cell microscopy and corneal pachymetry were performed preoperatively and 1 day, 3 to 4 days, 7 to 10 days, 50 to 60 days, and 90 to 100 days postoperatively. RESULTS: The mean endothelial cell loss was 7.9% ± 7.8% (SD) 1 week postoperatively and 8.1% ± 8.1% 3 months postoperatively in the study group and 12.1% ± 7.3% and 13.7% ± 8.4%, respectively, in the control group. The mean relative change in corneal thickness from the preoperative values was -0.0% ± 1.9% at 1 day, 2.8% ± 1.8% at 1 week, and 3.3% ± 1.7% at 3 months in the study group and -0.9% ± 2.3%, 2.4% ± 1.5%, and 3.2% ± 1.4%, respectively, in the control group. CONCLUSION: The femtosecond laser did not add to the endothelial damage caused by cataract surgery and might be beneficial in eyes with low preoperative endothelial cell values (eg, cornea guttata cases).


Subject(s)
Cornea/pathology , Corneal Endothelial Cell Loss/etiology , Lens Implantation, Intraocular , Low-Level Light Therapy/methods , Phacoemulsification/methods , Postoperative Complications , Aged , Aged, 80 and over , Cell Count , Cohort Studies , Corneal Endothelial Cell Loss/pathology , Endothelium, Corneal/pathology , Follow-Up Studies , Humans , Middle Aged , Prospective Studies , Time Factors
9.
Klin Monbl Augenheilkd ; 219(3): 113-6, 2002 Mar.
Article in German | MEDLINE | ID: mdl-11987037

ABSTRACT

BACKGROUND: Two independent epidemiological studies recently suggested the prophylactic relevance of an intraocular antibiosis against endophthalmitis after cataract surgery. The resulting intervention programme, however, has not only ethical drawbacks, but also has a health economical dimension, which will be focussed in this paper. MATERIAL AND METHODS: A cost analysis is performed to compare the direct costs saved by prevention of endophthalmitis cases and the costs generated by the prophylaxis itself. Furthermore, the clinics' indirect costs due to treatment of unprevented endophthalmitis cases are estimated. RESULTS: The overall gain in direct costs turns out to be about 368 000 Euro p. a., the indirect costs from the clinics' view can be reduced by about 260 000 Euro p. a. due to prevention of endophthalmitis cases by the antibiotic intervention. CONCLUSIONS: From an economical point of view, antibiotic prophylaxis can be suggested; the risk of longitudinally reduced antibiotic effectiveness of the antibiotic agents, however, strongly calls for an overall health political decision rather than for an immediate implementation of the corresponding intervention programme.


Subject(s)
Antibiotic Prophylaxis/economics , Cataract Extraction/economics , Endophthalmitis/economics , Gentamicins/economics , Postoperative Complications/economics , Costs and Cost Analysis , Cross-Sectional Studies , Drug Resistance , Endophthalmitis/epidemiology , Endophthalmitis/prevention & control , Gentamicins/administration & dosage , Gentamicins/adverse effects , Germany , Health Expenditures/statistics & numerical data , Humans , Incidence , National Health Programs/economics , Postoperative Complications/epidemiology , Postoperative Complications/prevention & control , Risk Assessment
SELECTION OF CITATIONS
SEARCH DETAIL